Friday 6 November 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
50.20
0.06
−0.12%
Follow PACS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 8 | 7 |
+8 more TTM periods Free account |
| 26.49% | 27.92% | 27.11% | 22.96% | ||
| 4.81% | 4.82% | 4.37% | 3.54% | ||
ROIC |
19.25% | 21.42% | 21.93% | 17.52% | |
Return on Tangible Assets |
22.83% | 20.63% | 18.71% | 15.09% | |
Average Days of Receivables |
47.99 | 47.60 | 49.27 | 48.45 | |
Free Cash Flow per Share |
2.83 | 2.89 | 2.43 | 1.92 | |
Free Cash Flow |
448.48 | 456.53 | 381.55 | 299.57 | |
Capital Expenditures |
(131.21) | (116.72) | (108.77) | (104.65) | |
| Other line items | |||||
Cash ROIC |
27.92% | 29.92% | 24.10% | 19.99% | |
Accounts Receivable Turnover |
7.90 | 7.85 | 7.37 | 7.46 | |
Accounts Payable Turnover |
24.71 | 27.82 | 24.05 | 24.55 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
13.68 | 12.68 | 14.46 | 15.56 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.30) | (0.30) | (0.31) | (0.33) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.39% | 7.97% | 7.89% | 7.85% | |
Share Based Compensation of Revenue |
1.88% | 1.34% | 1.15% | 1.02% | |
Interest Coverage |
16.21 | 13.88 | 13.68 | 10.92 | |
Operating CF/Net income |
2.09 | 2.13 | 2.01 | 2.11 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
(1.71) | (1.64) | (1.69) | (1.78) | |
Revenue per Share |
36.02 | 35.11 | 34.58 | 33.86 | |
Operating CF per Share |
3.66 | 3.63 | 3.12 | 2.59 | |
Capex per Share |
(0.83) | (0.74) | (0.69) | (0.67) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026